CA1273862A - Reactifs et necessaires pour le dosage quantitatif d'un acide nucleique viral dans un milieu biologique et procede de dosage de cet acide nucleique viral - Google Patents
Reactifs et necessaires pour le dosage quantitatif d'un acide nucleique viral dans un milieu biologique et procede de dosage de cet acide nucleique viralInfo
- Publication number
- CA1273862A CA1273862A CA000475889A CA475889A CA1273862A CA 1273862 A CA1273862 A CA 1273862A CA 000475889 A CA000475889 A CA 000475889A CA 475889 A CA475889 A CA 475889A CA 1273862 A CA1273862 A CA 1273862A
- Authority
- CA
- Canada
- Prior art keywords
- reagents
- nucleic acid
- dna
- cloned
- probe
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000003153 chemical reaction reagent Substances 0.000 title claims abstract description 84
- 230000003612 virological effect Effects 0.000 title claims abstract description 44
- 108020004707 nucleic acids Proteins 0.000 title claims abstract description 40
- 102000039446 nucleic acids Human genes 0.000 title claims abstract description 40
- 150000007523 nucleic acids Chemical class 0.000 title claims abstract description 39
- 238000000034 method Methods 0.000 title claims abstract description 38
- 239000000523 sample Substances 0.000 claims abstract description 71
- 238000009396 hybridization Methods 0.000 claims abstract description 34
- 108020005202 Viral DNA Proteins 0.000 claims abstract description 11
- 239000000203 mixture Substances 0.000 claims abstract description 11
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 9
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 7
- 108020003215 DNA Probes Proteins 0.000 claims abstract description 5
- 239000003298 DNA probe Substances 0.000 claims abstract description 5
- 208000002672 hepatitis B Diseases 0.000 claims abstract description 4
- 108020004414 DNA Proteins 0.000 claims description 51
- 239000003550 marker Substances 0.000 claims description 14
- 210000002966 serum Anatomy 0.000 claims description 12
- 241000700605 Viruses Species 0.000 claims description 11
- 238000012360 testing method Methods 0.000 claims description 11
- 239000012528 membrane Substances 0.000 claims description 10
- 238000006243 chemical reaction Methods 0.000 claims description 8
- 238000005259 measurement Methods 0.000 claims description 8
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 7
- 241000700721 Hepatitis B virus Species 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 4
- 238000011161 development Methods 0.000 claims description 3
- 239000004615 ingredient Substances 0.000 claims description 3
- 239000013642 negative control Substances 0.000 claims description 3
- 208000006454 hepatitis Diseases 0.000 claims description 2
- 231100000283 hepatitis Toxicity 0.000 claims description 2
- 208000037262 Hepatitis delta Diseases 0.000 claims 1
- 241000724709 Hepatitis delta virus Species 0.000 claims 1
- 101150010882 S gene Proteins 0.000 claims 1
- 150000007513 acids Chemical class 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 239000012141 concentrate Substances 0.000 claims 1
- 239000002245 particle Substances 0.000 description 31
- 230000000875 corresponding effect Effects 0.000 description 11
- 239000012472 biological sample Substances 0.000 description 6
- 208000015181 infectious disease Diseases 0.000 description 6
- 230000002285 radioactive effect Effects 0.000 description 6
- 239000000470 constituent Substances 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 238000012207 quantitative assay Methods 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 239000000020 Nitrocellulose Substances 0.000 description 3
- 239000004677 Nylon Substances 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 229920001220 nitrocellulos Polymers 0.000 description 3
- 229920001778 nylon Polymers 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 210000002845 virion Anatomy 0.000 description 3
- 241000701959 Escherichia virus Lambda Species 0.000 description 2
- 239000004952 Polyamide Substances 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 238000010411 cooking Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 230000002458 infectious effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 108020000999 Viral RNA Proteins 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- -1 acids nucleic acid Chemical class 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 238000000211 autoradiogram Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 239000012468 concentrated sample Substances 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000000424 optical density measurement Methods 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000002602 scintillography Methods 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/706—Specific hybridization probes for hepatitis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8403566 | 1984-03-07 | ||
| FR8403566A FR2560995B1 (fr) | 1984-03-07 | 1984-03-07 | Reactifs et necessaires pour le dosage quantitatif d'un acide nucleique viral dans un milieu biologique et procede de dosage de cet acide nucleique viral |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1273862A true CA1273862A (fr) | 1990-09-11 |
Family
ID=9301809
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000475889A Expired - Lifetime CA1273862A (fr) | 1984-03-07 | 1985-03-07 | Reactifs et necessaires pour le dosage quantitatif d'un acide nucleique viral dans un milieu biologique et procede de dosage de cet acide nucleique viral |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0159223B1 (enExample) |
| JP (1) | JPH062080B2 (enExample) |
| AT (1) | ATE43642T1 (enExample) |
| CA (1) | CA1273862A (enExample) |
| DE (1) | DE3570698D1 (enExample) |
| DK (1) | DK164880C (enExample) |
| FR (1) | FR2560995B1 (enExample) |
| GR (1) | GR850578B (enExample) |
| WO (1) | WO1985003951A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU1043788A (en) * | 1986-12-01 | 1988-06-30 | Mcdonnell Douglas Corporation | Method of identifying unknown organisms |
| US5780219A (en) * | 1989-07-11 | 1998-07-14 | Gen-Probe Incorporated | Nucleic acid amplification oligonucleotides and probes to human hepatitis B virus |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2444713A1 (fr) * | 1978-12-18 | 1980-07-18 | Pasteur Institut | Procede de production d'un adn comprenant le genome du virus de l'hepatite b et vecteur le comportant |
| FR2492985A1 (fr) * | 1980-10-24 | 1982-04-30 | Pasteur Institut | Procede d'etude et de detection d'un gene susceptible d'etre transcrit en un arn messager determine et de la capacite des cellules ou d'une fraction cellulaire d'en assurer la transcription et application au diagnostic in vitro de maladies dues a des anomalies genetiques ou a des adn etrangers |
| US4358535A (en) * | 1980-12-08 | 1982-11-09 | Board Of Regents Of The University Of Washington | Specific DNA probes in diagnostic microbiology |
| US4446237A (en) * | 1981-03-27 | 1984-05-01 | Life Technologies, Inc. | Method for detection of a suspect viral deoxyribonucleic acid in an acellular biological fluid |
| EP0062286A1 (en) * | 1981-03-31 | 1982-10-13 | Albert Einstein College Of Medicine Of Yeshiva University | Diagnostic test for hepatitis B virus |
| JPS58170496A (ja) * | 1982-03-31 | 1983-10-07 | アルバ−ト・アインシユタイン・カレツジ・オブ・メデイスン・オブ・イエシ−バ・ユニバ−シテイ− | Ｂ型肝炎ウイルスの診断テスト方法，その診断薬及びその診断試薬及びその診断テスト器具一式 |
| EP0119209A1 (en) * | 1982-09-20 | 1984-09-26 | President And Fellows Of Harvard College | Identification of microorganisms |
-
1984
- 1984-03-07 FR FR8403566A patent/FR2560995B1/fr not_active Expired
-
1985
- 1985-03-07 AT AT85400445T patent/ATE43642T1/de not_active IP Right Cessation
- 1985-03-07 JP JP60501079A patent/JPH062080B2/ja not_active Expired - Lifetime
- 1985-03-07 EP EP85400445A patent/EP0159223B1/fr not_active Expired
- 1985-03-07 CA CA000475889A patent/CA1273862A/fr not_active Expired - Lifetime
- 1985-03-07 GR GR850578A patent/GR850578B/el unknown
- 1985-03-07 DE DE8585400445T patent/DE3570698D1/de not_active Expired
- 1985-03-07 WO PCT/FR1985/000045 patent/WO1985003951A1/fr not_active Ceased
- 1985-11-06 DK DK511385A patent/DK164880C/da active
Also Published As
| Publication number | Publication date |
|---|---|
| GR850578B (enExample) | 1985-11-25 |
| JPH062080B2 (ja) | 1994-01-12 |
| DK164880C (da) | 1993-01-18 |
| EP0159223B1 (fr) | 1989-05-31 |
| DK511385D0 (da) | 1985-11-06 |
| WO1985003951A1 (fr) | 1985-09-12 |
| JPS61501306A (ja) | 1986-07-03 |
| EP0159223A1 (fr) | 1985-10-23 |
| FR2560995B1 (fr) | 1988-02-19 |
| ATE43642T1 (de) | 1989-06-15 |
| DK511385A (da) | 1985-11-06 |
| DK164880B (da) | 1992-08-31 |
| DE3570698D1 (en) | 1989-07-06 |
| FR2560995A1 (fr) | 1985-09-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3520298B2 (ja) | 被検体の検出に用いる組成物及び方法 | |
| JPH0421818B2 (enExample) | ||
| EP0805215A2 (en) | Diagnostic methods and probes | |
| Heller et al. | A simplified assay for porphyrins in whole blood | |
| JP2002505866A (ja) | 微生物の検出および特性付与 | |
| FR2487983A1 (fr) | Procede d'analyse immunometrique | |
| EP0097341B1 (en) | Sensitive tests for malignancies based on dna detection | |
| EP0461828A1 (en) | Detection of analytes having binding sites for at least two binding moieties | |
| US20010034057A1 (en) | Process and device for determining the activity of enzymes in liquids, or the concentration and/or activity of inhibitors in liquids | |
| WO1995004279A1 (fr) | Procede de dosage d'une substance immunologique au moyen de particules de latex magnetiques et de particules non-magnetiques | |
| CA1273862A (fr) | Reactifs et necessaires pour le dosage quantitatif d'un acide nucleique viral dans un milieu biologique et procede de dosage de cet acide nucleique viral | |
| JPH0421819B2 (enExample) | ||
| FR2582103A1 (fr) | Procede de determination d'une substance biologique dans un echantillon | |
| Daniels et al. | A comparison of three fluorophores for use in an optical biosensor for the measurement of prostate-specific antigen in whole blood | |
| EP0138938A1 (en) | Method and device for detecting microorganisms | |
| JP2009532692A (ja) | リポタンパク質センサ | |
| TWI745939B (zh) | 偵測周邊血液中ｅｇｆｒ基因突變腫瘤細胞之方法 | |
| EP0544578B1 (fr) | Trousse pour le dénombrement rapide des granulocytes et procédé utilisant ladite trousse | |
| CN106124768A (zh) | 一种一步均相saa检测试剂盒及其制备和使用方法 | |
| EP0686264B1 (fr) | Procede pour mettre en evidence l'affinite du fibrinogene et de ses derives aux formes filamentaires de levures, utilisation dans le domaine de la determination des levures pathogenes notamment en hemoculture | |
| EP1478767B1 (fr) | Methode et diagnostic serologique in vitro des endocartides infectieuses | |
| EP0586649B1 (fr) | Capteur moléculaire | |
| FR2723204A1 (fr) | Procede de detection et/ou de dosage de compose(s) infectueux dans un materiau biologique et support utilise pour ledit procede | |
| AU741858B2 (en) | Process and device for determining the activity of enzymes in liquids | |
| Liebes et al. | Quantitation of RNA tumor viruses by spectroscopy of density gradient gels |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKLA | Lapsed |